_id
691b1cf93c536f8df2318cf3
Ticker
GALD.SW
Name
Galderma Group N
Exchange
SW
Address
Zählerweg 10, Zug, Switzerland, 6300
Country
Switzerland
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
CHF
Website
https://www.galderma.com
Description
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Last Close
161
Volume
154390
Current Price
166.3
Change
0.3
Last Updated
2026-01-01T00:06:16.926Z
Image
https://logo.clearbit.com/www.galderma.com
Ipo Date
-
Market Cap
38483537920
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.999
Sentiment Sources
1
Rating
3.69
Strong Buy
3
Buy
5
Hold
4
Sell
0
Strong Sell
1
Current Quarter
2025-06-30
Revenue
2110625121
Cost Of Revenue
651810699
Gross Profit
1458814422
Operating Expenses
1132046888
Operating Income
326767533
Interest Expense
91391447
Pretax Income
217270233
Net Income
167263592
Eps
0.703659906216088
Dividends Per Share
-35349522
Shares Outstanding
234823853
Income Tax Expense
50006640
EBITDA
444886666
Operating Margin
15.482026142339278
Total Other Income Expense Net
-109497300
Cash
458000000
Short Term Investments
-
Receivables
931000000
Inventories
502000000
Total Current Assets
1910000000
Property Plant Equipment
672000000
Total Assets
12877000000
Payables
762000000
Short Term Debt
57000000
Long Term Debt
-
Total Liabilities
5147000000
Equity
7729000000
Bs_currency_symbol
-
Depreciation
136224987
Change In Working Capital
93977997
Cash From Operations
475063088
Capital Expenditures
37073888
Cash From Investing
-62939392
Cash From Financing
-426780814
Net Change In Cash
109005500
Cf_currency_symbol
CHF
PE
129.68
PB
5.114551486686505
ROE
2.1641039203001684
ROA
1.298932919158189
FCF
437989200
Fcf Percent
0.20751633989482873
Piotroski FScore
4
Health Score
63
Deep Value Investing Score
5
Defensive Investing Score
6.5
Dividend Investing Score
5
Economic Moat Investing Score
7.3
Garp Investing Score
4.5
Growth Investing Score
3.5
Momentum Investing Score
4.5
Net Net Investing Score
4
Quality Investing Score
6
Value Investing Score
4
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
2110625121
Quarters > 0 > income Statement > cost Of Revenue
651810699
Quarters > 0 > income Statement > gross Profit
1458814422
Quarters > 0 > income Statement > operating Expenses
1132046888
Quarters > 0 > income Statement > operating Income
326767533
Quarters > 0 > income Statement > interest Expense
91391447
Quarters > 0 > income Statement > pretax Income
217270233
Quarters > 0 > income Statement > net Income
167263592
Quarters > 0 > income Statement > eps
0.703659906216088
Quarters > 0 > income Statement > dividends Per Share
-35349522
Quarters > 0 > income Statement > shares Outstanding
237705162
Quarters > 0 > income Statement > income Tax Expense
50006640
Quarters > 0 > income Statement > EBITDA
444886666
Quarters > 0 > income Statement > operating Margin
15.482026142339278
Quarters > 0 > income Statement > total Other Income Expense Net
-109497300
Quarters > 0 > income Statement > currency_symbol
CHF
Quarters > 0 > balance Sheet > cash
458000000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
931000000
Quarters > 0 > balance Sheet > inventories
502000000
Quarters > 0 > balance Sheet > total Current Assets
1910000000
Quarters > 0 > balance Sheet > property Plant Equipment
672000000
Quarters > 0 > balance Sheet > total Assets
12877000000
Quarters > 0 > balance Sheet > payables
762000000
Quarters > 0 > balance Sheet > short Term Debt
57000000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
5147000000
Quarters > 0 > balance Sheet > equity
7729000000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
167263592
Quarters > 0 > cash Flow > depreciation
136224987
Quarters > 0 > cash Flow > change In Working Capital
93977997
Quarters > 0 > cash Flow > cash From Operations
475063088
Quarters > 0 > cash Flow > capital Expenditures
37073888
Quarters > 0 > cash Flow > cash From Investing
-62939392
Quarters > 0 > cash Flow > cash From Financing
-426780814
Quarters > 0 > cash Flow > net Change In Cash
109005500
Quarters > 0 > cash Flow > currency_symbol
CHF
Quarters > 0 > ratios > PE
0.703659906216088
Quarters > 0 > ratios > PB
5.114551486686505
Quarters > 0 > ratios > ROE
2.1641039203001684
Quarters > 0 > ratios > ROA
1.298932919158189
Quarters > 0 > ratios > FCF
437989200
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.20751633989482873
Quarters > 0 > health Score
63
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
1925123175
Quarters > 1 > income Statement > cost Of Revenue
599857221
Quarters > 1 > income Statement > gross Profit
1325265954
Quarters > 1 > income Statement > operating Expenses
1023593572
Quarters > 1 > income Statement > operating Income
301672381
Quarters > 1 > income Statement > interest Expense
159555045
Quarters > 1 > income Statement > pretax Income
203149320
Quarters > 1 > income Statement > net Income
160426931
Quarters > 1 > income Statement > eps
0.6745203406628758
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
237838537
Quarters > 1 > income Statement > income Tax Expense
42722389
Quarters > 1 > income Statement > EBITDA
494359077
Quarters > 1 > income Statement > operating Margin
15.670289824442014
Quarters > 1 > income Statement > total Other Income Expense Net
-98523061
Quarters > 1 > income Statement > currency_symbol
CHF
Quarters > 1 > balance Sheet > cash
457000000
Quarters > 1 > balance Sheet > short Term Investments
158593750
Quarters > 1 > balance Sheet > receivables
910000000
Quarters > 1 > balance Sheet > inventories
403000000
Quarters > 1 > balance Sheet > total Current Assets
1843000000
Quarters > 1 > balance Sheet > property Plant Equipment
578000000
Quarters > 1 > balance Sheet > total Assets
12617000000
Quarters > 1 > balance Sheet > payables
571000000
Quarters > 1 > balance Sheet > short Term Debt
36000000
Quarters > 1 > balance Sheet > long Term Debt
2636000000
Quarters > 1 > balance Sheet > total Liabilities
4827000000
Quarters > 1 > balance Sheet > equity
7790000000
Quarters > 1 > balance Sheet > currency_symbol
CHF
Quarters > 1 > cash Flow > net Income
160426931
Quarters > 1 > cash Flow > depreciation
131654709
Quarters > 1 > cash Flow > change In Working Capital
31098930
Quarters > 1 > cash Flow > cash From Operations
347190440
Quarters > 1 > cash Flow > capital Expenditures
54663390
Quarters > 1 > cash Flow > cash From Investing
-124096687
Quarters > 1 > cash Flow > cash From Financing
-159996981
Quarters > 1 > cash Flow > net Change In Cash
-90398500
Quarters > 1 > cash Flow > currency_symbol
CHF
Quarters > 1 > ratios > PE
0.6745203406628758
Quarters > 1 > ratios > PB
5.077348999114249
Quarters > 1 > ratios > ROE
2.0593957766367135
Quarters > 1 > ratios > ROA
1.2715140762463344
Quarters > 1 > ratios > FCF
292527050
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.15195238091713276
Quarters > 1 > health Score
58
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
520244145
Quarters > 2 > income Statement > cost Of Revenue
154772744
Quarters > 2 > income Statement > gross Profit
365471401
Quarters > 2 > income Statement > operating Expenses
304778528
Quarters > 2 > income Statement > operating Income
61594754
Quarters > 2 > income Statement > interest Expense
-59590655
Quarters > 2 > income Statement > pretax Income
37542595
Quarters > 2 > income Statement > net Income
28268134
Quarters > 2 > income Statement > eps
0.11885430492704385
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
237838537
Quarters > 2 > income Statement > income Tax Expense
9274461
Quarters > 2 > income Statement > EBITDA
86596823
Quarters > 2 > income Statement > operating Margin
11.83958620043672
Quarters > 2 > income Statement > total Other Income Expense Net
-24052159
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-
Quarters > 2 > cash Flow > depreciation
66834266
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
-
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.11885430492704385
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
54
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
995349640
Quarters > 3 > income Statement > cost Of Revenue
299593055
Quarters > 3 > income Statement > gross Profit
695756585
Quarters > 3 > income Statement > operating Expenses
555167940
Quarters > 3 > income Statement > operating Income
140588645
Quarters > 3 > income Statement > interest Expense
217075934
Quarters > 3 > income Statement > pretax Income
34585705
Quarters > 3 > income Statement > net Income
21110755
Quarters > 3 > income Statement > eps
0.08884390795585197
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
237616236
Quarters > 3 > income Statement > income Tax Expense
13474950
Quarters > 3 > income Statement > EBITDA
188649300
Quarters > 3 > income Statement > operating Margin
14.124548736462096
Quarters > 3 > income Statement > total Other Income Expense Net
-106002940
Quarters > 3 > income Statement > currency_symbol
CHF
Quarters > 3 > balance Sheet > cash
345857050
Quarters > 3 > balance Sheet > short Term Investments
-3595210
Quarters > 3 > balance Sheet > receivables
822870280
Quarters > 3 > balance Sheet > inventories
371908620
Quarters > 3 > balance Sheet > total Current Assets
1610705690
Quarters > 3 > balance Sheet > property Plant Equipment
494230000
Quarters > 3 > balance Sheet > total Assets
11300093070
Quarters > 3 > balance Sheet > payables
435081500
Quarters > 3 > balance Sheet > short Term Debt
29356580
Quarters > 3 > balance Sheet > long Term Debt
2915000000
Quarters > 3 > balance Sheet > total Liabilities
4444038510
Quarters > 3 > balance Sheet > equity
6856054560
Quarters > 3 > balance Sheet > currency_symbol
CHF
Quarters > 3 > cash Flow > net Income
21110755
Quarters > 3 > cash Flow > depreciation
63781430
Quarters > 3 > cash Flow > change In Working Capital
-86688845
Quarters > 3 > cash Flow > cash From Operations
78289681
Quarters > 3 > cash Flow > capital Expenditures
13474950
Quarters > 3 > cash Flow > cash From Investing
-160137984
Quarters > 3 > cash Flow > cash From Financing
109427622
Quarters > 3 > cash Flow > net Change In Cash
143460010
Quarters > 3 > cash Flow > currency_symbol
CHF
Quarters > 3 > ratios > PE
0.08884390795585197
Quarters > 3 > ratios > PB
5.763603498336222
Quarters > 3 > ratios > ROE
0.3079140461215933
Quarters > 3 > ratios > ROA
0.18681930201128866
Quarters > 3 > ratios > FCF
64814731
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.06511755105472285
Quarters > 3 > health Score
47
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
4440000000
Annuals > 0 > income Statement > cost Of Revenue
1355000000
Annuals > 0 > income Statement > gross Profit
3085000000
Annuals > 0 > income Statement > operating Expenses
2440000000
Annuals > 0 > income Statement > operating Income
645000000
Annuals > 0 > income Statement > interest Expense
317040324
Annuals > 0 > income Statement > pretax Income
310000000
Annuals > 0 > income Statement > net Income
231000000
Annuals > 0 > income Statement > eps
0.9721557915764645
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
237616236
Annuals > 0 > income Statement > income Tax Expense
79000000
Annuals > 0 > income Statement > EBITDA
959000000
Annuals > 0 > income Statement > operating Margin
14.527027027027026
Annuals > 0 > income Statement > total Other Income Expense Net
-335000000
Annuals > 0 > income Statement > currency_symbol
CHF
Annuals > 0 > balance Sheet > cash
457000000
Annuals > 0 > balance Sheet > short Term Investments
158593750
Annuals > 0 > balance Sheet > receivables
910000000
Annuals > 0 > balance Sheet > inventories
403000000
Annuals > 0 > balance Sheet > total Current Assets
1843000000
Annuals > 0 > balance Sheet > property Plant Equipment
578000000
Annuals > 0 > balance Sheet > total Assets
12617000000
Annuals > 0 > balance Sheet > payables
571000000
Annuals > 0 > balance Sheet > short Term Debt
36000000
Annuals > 0 > balance Sheet > long Term Debt
2636000000
Annuals > 0 > balance Sheet > total Liabilities
4827000000
Annuals > 0 > balance Sheet > equity
7790000000
Annuals > 0 > balance Sheet > currency_symbol
CHF
Annuals > 0 > cash Flow > net Income
231000000
Annuals > 0 > cash Flow > depreciation
293000000
Annuals > 0 > cash Flow > change In Working Capital
-148000000
Annuals > 0 > cash Flow > cash From Operations
429765772
Annuals > 0 > cash Flow > capital Expenditures
275000000
Annuals > 0 > cash Flow > cash From Investing
-287097627
Annuals > 0 > cash Flow > cash From Financing
-51078718
Annuals > 0 > cash Flow > net Change In Cash
53061510
Annuals > 0 > cash Flow > currency_symbol
CHF
Annuals > 0 > ratios > PE
0.9721557915764645
Annuals > 0 > ratios > PB
4.944491894172015
Annuals > 0 > ratios > ROE
2.9653401797175865
Annuals > 0 > ratios > ROA
1.8308631211857016
Annuals > 0 > ratios > FCF
154765772
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.03485715585585586
Annuals > 0 > health Score
48
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
3668026851
Annuals > 1 > income Statement > cost Of Revenue
1107049092
Annuals > 1 > income Statement > gross Profit
2560977759
Annuals > 1 > income Statement > operating Expenses
2043264486
Annuals > 1 > income Statement > operating Income
517713273
Annuals > 1 > income Statement > interest Expense
503963901
Annuals > 1 > income Statement > pretax Income
9795304
Annuals > 1 > income Statement > net Income
-48109776
Annuals > 1 > income Statement > eps
-0.20251083625334468
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
237566428
Annuals > 1 > income Statement > income Tax Expense
61198184
Annuals > 1 > income Statement > EBITDA
690442572
Annuals > 1 > income Statement > operating Margin
14.114217099006726
Annuals > 1 > income Statement > total Other Income Expense Net
-507917969
Annuals > 1 > income Statement > currency_symbol
CHF
Annuals > 1 > balance Sheet > cash
309349224
Annuals > 1 > balance Sheet > short Term Investments
107057880
Annuals > 1 > balance Sheet > receivables
531226128
Annuals > 1 > balance Sheet > inventories
353001276
Annuals > 1 > balance Sheet > total Current Assets
1359437604
Annuals > 1 > balance Sheet > property Plant Equipment
445401180
Annuals > 1 > balance Sheet > total Assets
10489445112
Annuals > 1 > balance Sheet > payables
468649776
Annuals > 1 > balance Sheet > short Term Debt
53240364
Annuals > 1 > balance Sheet > long Term Debt
4747400000
Annuals > 1 > balance Sheet > total Liabilities
5973350160
Annuals > 1 > balance Sheet > equity
4516094952
Annuals > 1 > balance Sheet > currency_symbol
CHF
Annuals > 1 > cash Flow > net Income
-51402880
Annuals > 1 > cash Flow > depreciation
248387343
Annuals > 1 > cash Flow > change In Working Capital
-30644024
Annuals > 1 > cash Flow > cash From Operations
148636999
Annuals > 1 > cash Flow > capital Expenditures
102023004
Annuals > 1 > cash Flow > cash From Investing
-156095809
Annuals > 1 > cash Flow > cash From Financing
127338953
Annuals > 1 > cash Flow > net Change In Cash
-13903290
Annuals > 1 > cash Flow > currency_symbol
CHF
Annuals > 1 > ratios > PE
-0.20251083625334468
Annuals > 1 > ratios > PB
8.527171901411341
Annuals > 1 > ratios > ROE
-1.0652959362312362
Annuals > 1 > ratios > ROA
-0.45864938980387127
Annuals > 1 > ratios > FCF
46613995
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.012708193503897553
Annuals > 1 > health Score
17
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
3591331356
Annuals > 2 > income Statement > cost Of Revenue
1140347748
Annuals > 2 > income Statement > gross Profit
2450983608
Annuals > 2 > income Statement > operating Expenses
2123969312
Annuals > 2 > income Statement > operating Income
327014300
Annuals > 2 > income Statement > interest Expense
378205786
Annuals > 2 > income Statement > pretax Income
-49567879
Annuals > 2 > income Statement > net Income
-94073913
Annuals > 2 > income Statement > eps
-0.39598992918309145
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
237566428
Annuals > 2 > income Statement > income Tax Expense
42977930
Annuals > 2 > income Statement > EBITDA
592235880
Annuals > 2 > income Statement > operating Margin
9.105656582026624
Annuals > 2 > income Statement > total Other Income Expense Net
-376582179
Annuals > 2 > income Statement > currency_symbol
CHF
Annuals > 2 > balance Sheet > cash
216404280
Annuals > 2 > balance Sheet > short Term Investments
185040
Annuals > 2 > balance Sheet > receivables
731463120
Annuals > 2 > balance Sheet > inventories
409215960
Annuals > 2 > balance Sheet > total Current Assets
1393906320
Annuals > 2 > balance Sheet > property Plant Equipment
370820160
Annuals > 2 > balance Sheet > total Assets
11485987920
Annuals > 2 > balance Sheet > payables
556880557
Annuals > 2 > balance Sheet > short Term Debt
381393375
Annuals > 2 > balance Sheet > long Term Debt
5245200000
Annuals > 2 > balance Sheet > total Liabilities
7351546680
Annuals > 2 > balance Sheet > equity
4134441240
Annuals > 2 > balance Sheet > currency_symbol
CHF
Annuals > 2 > cash Flow > net Income
-91072115
Annuals > 2 > cash Flow > depreciation
277700000
Annuals > 2 > cash Flow > change In Working Capital
-74972611
Annuals > 2 > cash Flow > cash From Operations
106298747
Annuals > 2 > cash Flow > capital Expenditures
152332886
Annuals > 2 > cash Flow > cash From Investing
-70483805
Annuals > 2 > cash Flow > cash From Financing
-68860194
Annuals > 2 > cash Flow > net Change In Cash
-42817895
Annuals > 2 > cash Flow > currency_symbol
CHF
Annuals > 2 > ratios > PE
-0.39598992918309145
Annuals > 2 > ratios > PB
9.314322236878617
Annuals > 2 > ratios > ROE
-2.275371871048771
Annuals > 2 > ratios > ROA
-0.8190319688234532
Annuals > 2 > ratios > FCF
-46034139
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-0.01281812632607438
Annuals > 2 > health Score
18
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3123956893
Annuals > 3 > income Statement > cost Of Revenue
945260040
Annuals > 3 > income Statement > gross Profit
2178696853
Annuals > 3 > income Statement > operating Expenses
1877811778
Annuals > 3 > income Statement > operating Income
300885080
Annuals > 3 > income Statement > interest Expense
320816083
Annuals > 3 > income Statement > pretax Income
-72867032
Annuals > 3 > income Statement > net Income
-141071306
Annuals > 3 > income Statement > eps
-0.5938183571964974
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
237566428
Annuals > 3 > income Statement > income Tax Expense
4114198
Annuals > 3 > income Statement > EBITDA
476058522
Annuals > 3 > income Statement > operating Margin
9.631537511743764
Annuals > 3 > income Statement > total Other Income Expense Net
-373752112
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
259222175
Annuals > 3 > balance Sheet > short Term Investments
2460105
Annuals > 3 > balance Sheet > receivables
666506225
Annuals > 3 > balance Sheet > inventories
315986820
Annuals > 3 > balance Sheet > total Current Assets
1382487895
Annuals > 3 > balance Sheet > property Plant Equipment
311431070
Annuals > 3 > balance Sheet > total Assets
11454977800
Annuals > 3 > balance Sheet > payables
458157060
Annuals > 3 > balance Sheet > short Term Debt
389917019
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
7310612025
Annuals > 3 > balance Sheet > equity
4144365775
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-156200000
Annuals > 3 > cash Flow > depreciation
253100000
Annuals > 3 > cash Flow > change In Working Capital
23405220
Annuals > 3 > cash Flow > cash From Operations
178921936
Annuals > 3 > cash Flow > capital Expenditures
117026100
Annuals > 3 > cash Flow > cash From Investing
-487761129
Annuals > 3 > cash Flow > cash From Financing
290005305
Annuals > 3 > cash Flow > net Change In Cash
259222175
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.5938183571964974
Annuals > 3 > ratios > PB
9.292017179347544
Annuals > 3 > ratios > ROE
-3.403929905294134
Annuals > 3 > ratios > ROA
-1.2315284102951294
Annuals > 3 > ratios > FCF
61895836
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
0.019813281079099705
Annuals > 3 > health Score
18
Valuation > metrics > PE
129.68
Valuation > metrics > PB
5.114551486686505
Valuation > final Score
1
Valuation > verdict
244.6% Overvalued
Profitability > metrics > ROE
2.1641039203001684
Profitability > metrics > ROA
8.75725612565445
Profitability > metrics > Net Margin
0.07924836596313779
Profitability > final Score
42
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6659334972182689
Risk > metrics > Interest Coverage
3.575471706887407
Risk > final Score
62
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.3321123321123323
Liquidity > metrics > Quick Ratio
1.7191697191697193
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
49.22651000885752
Prev Valuations > 1
70
Prev Valuations > 2
42.36396501663778
Prev Profitabilities > 0
43
Prev Profitabilities > 1
43
Prev Profitabilities > 2
8
Prev Risks > 0
56
Prev Risks > 1
34
Prev Risks > 2
51
Prev Liquidities > 0
100
Prev Liquidities > 1
50
Prev Liquidities > 2
100
Updated At
2026-01-20T23:11:09.992Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-05
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-24
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.82
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0.82
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-12-31
Earnings History > 2 > report Date
2025-03-05
Earnings History > 2 > date
2024-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.77
Earnings History > 2 > eps Estimate
0.84
Earnings History > 2 > eps Difference
-0.07
Earnings History > 2 > surprise Percent
-8.3333
Earnings History > 3 > period
2024-06-30
Earnings History > 3 > report Date
2024-07-25
Earnings History > 3 > date
2024-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.55
Earnings History > 3 > eps Estimate
1.12
Earnings History > 3 > eps Difference
-0.57
Earnings History > 3 > surprise Percent
-50.8929
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Stock Price
CHF0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AEvaluating Galderma Group (SWX:GALD) After a 60% Year-to-Date Rally and Strong Shareholder Returns Yahoo Finance
Read more →How the Story Around Galderma Is Evolving with Analyst Upgrades and Growth Momentum - Yahoo Finance
11/17/2025
How the Story Around Galderma Is Evolving with Analyst Upgrades and Growth Momentum Yahoo Finance
Read more →Showing 2 of 5
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
3
Buy
5
Hold
4
Sell
0
Strong Sell
1
Sentiment:
Bullish
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Galderma Group N
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-06-30
EPS Actual
0.82
EPS Estimate
0
EPS Difference
0.82
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
CHF 0
Cost Of Revenue
CHF 0
Gross Profit
CHF 0
Operating Expenses
CHF 0
Operating Income
CHF 0
Interest Expense
CHF 0
Pretax Income
CHF 0
Net Income
CHF 0
Income Tax Expense
CHF 0
EBITDA
CHF 0
Total Other Income Expense Net
CHF 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
CHF 0
Short Term Investments
CHF 0
Receivables
CHF 0
Inventories
CHF 0
Total Current Assets
CHF 0
Property Plant Equipment
CHF 0
Total Assets
CHF 0
Payables
CHF 0
Short Term Debt
CHF 0
Long Term Debt
CHF 0
Total Liabilities
CHF 0
Equity
CHF 0
(Last Updated 2025-06-30)
Net Income
CHF 0
Depreciation
CHF 0
Change In Working Capital
CHF 0
Cash From Operations
CHF 0
Capital Expenditures
CHF 0
Cash From Investing
CHF 0
Cash From Financing
CHF 0
Net Change In Cash
CHF 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.